Rebecca A. Dent
11 Hospital Crescent
Singapore, 169610, Singapore
Singapore, 169610, Singapore
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 136 publications
Stakeholder priorities for advancing integrative oncology across a pluralistic health system: a qualitative study from Singapore.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: May 08, 2026
Datopotamab deruxtecan in patients with untreated, advanced triple-negative breast cancer (TROPION-Breast02): a randomised, open-label, international, phase III trial.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: March 26, 2026
Metastatic breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: March 24, 2026
ASO Visual Abstract: Surgical Outcomes After Neoadjuvant Pembrolizumab Plus Chemotherapy for Triple-Negative Breast Cancer-Results from the Randomized, Placebo-Controlled Phase 3 KEYNOTE-522 Study.
Journal: Annals of surgical oncology
Published: March 12, 2026
Correction: Part II: consensus statements and expert recommendations for BRCA-associated breast cancer in the Asia-Pacific region: clinical management.
Journal: Frontiers in oncology
Published: February 10, 2026
Advancing breast cancer research through real-world data from the Singapore Joint Breast Cancer Registry.
Journal: ESMO real world data and digital oncology
Published: February 06, 2026
A multi-ancestry genome-wide study of tamoxifen metabolism and breast cancer recurrence.
Journal: NPJ breast cancer
Published: December 03, 2025
Rethinking First-Line Therapy and Beyond: HER2-Positive and Hormone Receptor-Positive/HER2-Negative Metastatic Breast Cancer-Commentary Based on a Live Symposium Presented at the 2025 ESMO Congress in Berlin, Germany.
Journal: Clinical breast cancer
Published: October 31, 2025
Treatment patterns and clinical outcomes according to PD-L1 status in >2000 patients with early-stage or metastatic triple-negative breast cancer treated in the real-world setting: VANESSA study results.
Journal: Breast (Edinburgh, Scotland)
Published: October 08, 2025
Surgical Outcomes After Neoadjuvant Pembrolizumab Plus Chemotherapy for Triple-Negative Breast Cancer: Results from the Randomized, Placebo-Controlled Phase 3 KEYNOTE-522 Study.
Journal: Annals of surgical oncology
Published: October 03, 2025
Understanding Barriers to Clinical Cancer Research in the Asia-Pacific.
Journal: JCO global oncology
Published: September 19, 2025
Evaluating the impact of relative dose intensity on efficacy of trastuzumab deruxtecan for metastatic breast cancer in the real-world clinical setting.
Journal: Annals of the Academy of Medicine, Singapore
Published: September 10, 2025
Last Updated: 09/26/2026